Development and Validation of New UV-Spectrophotometric Method for The Quantitation of Retigabine In Pure and Formulations

Venkateswara Reddy Billa; Naveen Reddy Seelam

doi:10.46243/jstj.2020.v5.i2.312

Authors

Venkateswara Reddy Billa
Naveen Reddy Seelam

DOI:

https://doi.org/10.46243/jstj.2020.v5.i2.312

Keywords:

UV-Spectrophotometric, Retigabine, Validation

Abstract

A simple, accurate, precise, economical and reproducible UV-spectrophotometric method has been developed for the simultaneous estimation of Retigabine in bulk and in combined tablet dosage form. The stock solutions were prepared in methanol followed by the further required dilutions with distilled water. This method involves the formation and solving of simultaneous equations at 254 nm as absorbance maxima of Retigabine respectively. Linearity obeyed the concentration range of 25µg/mL to 75µg/mL for Retigabine respectively. The results of analysis were validated statistically and by recovery studies. The % RSD for the recovery study was less than 2.0. The proposed method can be effectively applied for the estimation of Retigabine in bulk and in combined tablet dosage form

References

Satyanarayana, P.V.V., Alavala siva madhavi., New spectrophotometric methods for the quantitative estimation of ezogabine in formulation. International Journal of Research in Pharmacy and Chemistry 2012, 2, 4, 1093-1098

Ravisankar panchamorthy., Lokaparani, C. H., Devadasu, C.H.,Srinivasa babu, P., Novel sensitive spectrophotometric methods for determination of retigabine in bulk and pharmaceutical formulation, International Journal of Pharma Science. 2014, 4, 6, 773- 779

Lakshmi, B., Saraswathi, K., Reddy, T.V., RP-HPLC method development and validation for the analysis of ezogabine in pharmaceutical dosage form Int.J.A.PS.BMS, 2012, 1, 1, 7- 14

Satyanarayana, P.V.V., Alavala Siva Madhavi., Validated RP HPLC method for the estimation of ezogabine in tablet dosage form, International Journal of Research in Pharmaceutical and Biomedical Sciences, 2012, 3, 2, 955-959

Wang, X., Zhou, H., Zheng, J., Huang, C., Liu, W., Yu, L., Zeng, S.,Identification and characterization of four process-related impurities in retigabine. J Pharm Biomed Anal. 2012, 71,148-51

Douša, M., Srbek, J., Rádl, S., Cerný, J., Klecán, O., Havlíček, J.,Tkadlecová, M., Pekárek, T., Gibala, P., Novak ova, S.,Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine. J Pharm Biomed Anal. 2014, 94, 71-6

Dengfeng Zhang., Xin Song., Jiangtao Su., Isolation, identification and structure elucidation of two novel process-related impurities of retigabine. J Pharm Biomed Anal. 2014, 99, 22-27

Pawanjeet J Chhabda., Balaji, M., Srinivasarao, V., Development and validation of simple stability indicating LC method for analysis of ezogabine in bulk drug and pharmaceutical dosage form. J.Sci.Res.Phar.2013,2,4,1-6

Xifeng Wu., Feng Shao., Chunlei Tao., Jie Li., Development and validation of simple stability indicating HPLC method for the determination of retigabine and related substances in drug substances. J. Chin. Pharm. Sci. 2015, 24, 4, 241-249